ACA Exchange Plan Premiums May Rise More Sharply in 2017
This week in healthcare: a Kaiser report indicates ACA Exchange premiums may rise more in 2017 and FDA Commissioner Pazdur chides the biopharmaceutical industry.
Analysis of 2017 Premium Changes and Insurer Participation in the Affordable Care Act’s Health Insurance Marketplaces
This report from the Kaiser Family Foundation takes a look ahead at ACA insurance marketplace premiums for 2017 and says “there is reason to believe that increases will be higher than in recent years.”
The FDA’s Richard Pazdur urges the biopharmaceutical industry to “Stay focused on the cutting edge, and lose the me-too drugs in the cancer pipeline.”
Looking ahead to the start of MACRA evaluation, which begins in 2017, ASCO hosted a town hall session at its recent Annual Meeting and offered five important tips to help oncologists prepare.
The American College of Radiology released this statement declaring its support of a Senate bill that “would extend until 2019 the current two-year delay in implementation of U.S. Preventive Services Task Force (USPSTF) screening mammography recommendations,” which would no longer guarantee full coverage for mammograms for women 40-49.
In pursuit of its “cancer moonshot” initiative, the White House (via Energy Secretary Ernest Monitz) announced it will use supercomputers with the goal to “find patterns in the data on cancer patients to understand the disease better, and accelerate the search for new treatments.”
Stanford Scientists Create “Guided Chemotherapy Missiles” that Target Cancer Cells and Spare Healthy Ones
A team of Stanford scientists has created a chemotherapy that may be able to distinguish between healthy cells and cancerous cells.
This article summarizes several sessions from the ASCO Annual Meeting, including one that argues “We need to remember that payers aren’t the only ones paying for health services. The patients are also paying, and depending on how you’re insured or if you’re insured, you may pay a lot.”
A recent study has found that “measuring PSA [prostate-specific antigen] levels in younger men (between the ages of 40 and 59) could accurately predict future risk of lethal prostate cancer later in life.”
This article asks the question, “how do you get a [millennial] person who doesn’t want to be committed, to make ongoing payments for something they don’t feel they need, from someone they don’t trust?” and offers seven strategies to attract millennials to health insurance.
Want more health care landscape updates and insights? Follow us on Twitter @innovpartners.